Guardant Health
GH
#1653
Rank
โ‚ฌ11.07 B
Marketcap
85,30ย โ‚ฌ
Share price
2.53%
Change (1 day)
86.38%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -2,89ย โ‚ฌ

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -2,72ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,01ย โ‚ฌ an increase over its 2023 EPS that were of -3,62ย โ‚ฌ.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,89ย โ‚ฌ-4.16%
2024-3,01ย โ‚ฌ-16.82%
2023-3,62ย โ‚ฌ-33.13%
2022-5,41ย โ‚ฌ60%
2021-3,38ย โ‚ฌ55.04%
2020-2,18ย โ‚ฌ207.14%
2019-0,71ย โ‚ฌ-19.81%
2018-0,89ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-2,34ย โ‚ฌ-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-1,81ย โ‚ฌ-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA